215 related articles for article (PubMed ID: 23219284)
81. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.
Hansson L; Lindholm LH; Ekbom T; Dahlöf B; Lanke J; Scherstén B; Wester PO; Hedner T; de Faire U
Lancet; 1999 Nov; 354(9192):1751-6. PubMed ID: 10577635
[TBL] [Abstract][Full Text] [Related]
82. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group.
Wassertheil-Smoller S; Fann C; Allman RM; Black HR; Camel GH; Davis B; Masaki K; Pressel S; Prineas RJ; Stamler J; Vogt TM
Arch Intern Med; 2000 Feb; 160(4):494-500. PubMed ID: 10695689
[TBL] [Abstract][Full Text] [Related]
83. Relationship between body mass index (BMI) and changes in plasma total and HDL-cholesterol levels during treatment of hypertension in African patients.
Ahaneku JE; Agbedana OE; Taylor OG
Acta Med Okayama; 1995 Oct; 49(5):267-70. PubMed ID: 8585398
[TBL] [Abstract][Full Text] [Related]
84. Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.
Thom S; Stettler C; Stanton A; Witt N; Tapp R; Chaturvedi N; Allemann S; Mayet J; Sever P; Poulter N; O'Brien E; Hughes A
Hypertension; 2009 Aug; 54(2):405-8. PubMed ID: 19528363
[TBL] [Abstract][Full Text] [Related]
85. The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats.
Kanno Y; Okada H; Moriwaki K; Nagao S; Takahashi H; Suzuki H
Hypertens Res; 2002 Nov; 25(6):939-43. PubMed ID: 12484519
[TBL] [Abstract][Full Text] [Related]
86. Fenfluramine potentiation of antihypertensive effects of thiazides.
Lake CR; Ziegler MG; Coleman MD; Kopin IJ
Clin Pharmacol Ther; 1980 Jul; 28(1):22-7. PubMed ID: 7389251
[TBL] [Abstract][Full Text] [Related]
87. Effect of body size and intensive blood pressure management on cardiovascular and serious adverse events.
Pei J; Wang X; Zheng K; Su W; Hu X
J Hypertens; 2022 May; 40(5):878-887. PubMed ID: 35506278
[TBL] [Abstract][Full Text] [Related]
88. [CEA comprehensive evaluation for Western and traditional Chinese hypotensive drugs].
Wang Y; Li L; He BR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep; 21(9):663-6. PubMed ID: 12575552
[TBL] [Abstract][Full Text] [Related]
89. Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs.
Schindler C; Bramlage P; Thoenes M; Bramlage C; Kirch W
Clin Drug Investig; 2007; 27(10):707-17. PubMed ID: 17803346
[TBL] [Abstract][Full Text] [Related]
90. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
Czernichow S; Ninomiya T; Huxley R; Kengne AP; Batty GD; Grobbee DE; Woodward M; Neal B; Chalmers J
Hypertension; 2010 May; 55(5):1193-8. PubMed ID: 20212271
[TBL] [Abstract][Full Text] [Related]
91. Definition of the effective dose of the converting-enzyme inhibitor benazepril.
Whalen JJ
Am Heart J; 1989 Mar; 117(3):728-34. PubMed ID: 2645756
[TBL] [Abstract][Full Text] [Related]
92. 'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
van Jaarsveld BC; Derkx FH; Krijnen P; Pieterman H; Man in't Veld AJ; Woittiez AJ; Dees A; Postma CT; Schalekamp MA
Contrib Nephrol; 1996; 119():54-8. PubMed ID: 8783591
[No Abstract] [Full Text] [Related]
93. Effect of intensive and standard blood pressure control on cardiovascular outcomes based on body mass index: sub-analysis of the sprint trial.
Fugar S; Okoh AK; Dodoo C; Kolkailah AA; Okyne E; Özturk E; Solomon A; Yeboah NAA; Campagnoli T; Volgman A; Williams K
J Hum Hypertens; 2020 Nov; 34(11):778-786. PubMed ID: 31911613
[TBL] [Abstract][Full Text] [Related]
94. Development and validation of different methods manipulating zero order and first order spectra for determination of the partially overlapped mixture benazepril and amlodipine: A comparative study.
Hemdan A
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jul; 164():52-60. PubMed ID: 27078209
[TBL] [Abstract][Full Text] [Related]
95. Safety of Amlodipine in Early Pregnancy.
Mito A; Murashima A; Wada Y; Miyasato-Isoda M; Kamiya CA; Waguri M; Yoshimatsu J; Yakuwa N; Watanabe O; Suzuki T; Arata N; Mikami M; Ito S
J Am Heart Assoc; 2019 Aug; 8(15):e012093. PubMed ID: 31345083
[TBL] [Abstract][Full Text] [Related]
96. Obesity and cardiovascular outcomes: a review.
Ghoorah K; Campbell P; Kent A; Maznyczka A; Kunadian V
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):77-85. PubMed ID: 24526749
[TBL] [Abstract][Full Text] [Related]
97. Severe neuromuscular complications possibly associated with amlodipine.
Phillips BB; Muller BA
Ann Pharmacother; 1998 Nov; 32(11):1165-7. PubMed ID: 9825082
[TBL] [Abstract][Full Text] [Related]
98. [Coronary disease risk and prevalence of heart disease in primary care patients with hypertension and renal disease].
Cosín-Aguilar J; Hernándiz-Martínez A; Arístegui-Urrestarazu R; Masramón-Morell X; Aguilar-Llopis A; Rodríguez-Padial L; Zamorano-Gómez JL;
Rev Esp Cardiol; 2006 Oct; 59(10):1026-32. PubMed ID: 17125712
[TBL] [Abstract][Full Text] [Related]
99. [Do obese patients need different antihypertensive drugs?].
Wirth A
MMW Fortschr Med; 2015 Jul; 157(13):37. PubMed ID: 26206028
[No Abstract] [Full Text] [Related]
100. Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program.
Somes GW; Kritchevsky SB; Shorr RI; Pahor M; Applegate WB
Am J Epidemiol; 2002 Jul; 156(2):132-8. PubMed ID: 12117704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
